Edition:
India

Indivior PLC (INDV.L)

INDV.L on London Stock Exchange

393.00GBp
15 Dec 2017
Change (% chg)

3.20 (+0.82%)
Prev Close
389.80
Open
387.70
Day's High
393.00
Day's Low
385.50
Volume
2,414,750
Avg. Vol
3,036,861
52-wk High
421.50
52-wk Low
246.50

Select another date:

Tue, Dec 12 2017

BRIEF-Indivior Announces NDA Acceptance Of RBP-7000 Risperidone Monthly Depot

* INDIVIOR ANNOUNCES NDA ACCEPTANCE OF RBP-7000 RISPERIDONE MONTHLY DEPOT

U.S. FDA accepts application for Indivior's new schizophrenia drug

U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

U.S. FDA accepts application for Indivior's new schizophrenia drug

Dec 12 U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

BRIEF-‍Indivior Says FDA Accepts Application For New Schizophrenia Drug

* ‍INDIVIOR ANNOUNCES NDA ACCEPTANCE OF RBP-7000 RISPERIDONE MONTHLY DEPOT​

LPC-Indivior launches US$485m-equiv loan refi

LONDON, Dec 5 Pharmaceuticals company Indivior has launched a US$485m-equivalent loan to refinance existing debt, banking sources said.

Indivior drug to fight opioid addiction approved by U.S. FDA

Indivior's experimental drug to help fight America's growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, boosting its sales prospects as competitors threaten revenues from an older product.

UK's Indivior posts profit in third quarter as costs fall

British drugmaker Indivior on Thursday reported a quarterly profit compared with a year-ago loss, as it benefited from lower costs.

UPDATE 1-UK's Indivior posts profit in 3rd quarter as costs fall

Nov 2 British drugmaker Indivior on Thursday reported a quarterly profit compared with a year-ago loss, as it benefited from lower costs.

UK's Indivior posts profit compared with year-ago loss

Nov 2 British drugmaker Indivior posted a quarterly profit compared with a year-ago loss, helped by strength in its U.S. business and lower costs.

BRIEF-Indivior says Q3 net revenue $‍275​ mln vs. $268 mln

* Q3 NET REVENUE $‍275​ MILLION VERSUS $268 MILLION A YEAR AGO

Select another date: